Glycerol-3-phosphate acyltransferases (GPATs) initiate lipid biosynthesis by acylating glycerol-3-phosphate, forming lysophosphatidic acid (LPA). In F. tularensis, plsY may:
Synthesize membrane lipids: Contributing to outer membrane integrity and virulence.
Regulate metabolic pathways: Interacting with glycolytic intermediates (e.g., glyceraldehyde-3-phosphate) as part of carbon metabolism .
To study plsY activity, researchers may use:
In vitro acyltransferase assays: Measure LPA formation using radiolabeled acyl-CoA and glycerol-3-phosphate.
Membrane lipid profiling: Analyze lipid composition in F. tularensis mutants lacking plsY.
KEGG: fta:FTA_0889
The isolation and purification of recombinant F. tularensis proteins typically involves:
Gene cloning strategy: Primer pairs are designed based on genomic sequences for amplification of target genes from isolated F. tularensis genomic DNA .
Expression system selection: Escherichia coli is commonly used as a heterologous expression host. For example, acid phosphatase from F. tularensis has been successfully expressed in E. coli, yielding recombinant enzyme with attributes equivalent to the native enzyme .
Purification approach: Researchers typically employ His-tag affinity chromatography for initial purification, followed by additional steps such as ion exchange or size exclusion chromatography to achieve high purity.
Quality control: Verification includes SDS-PAGE analysis, Western blotting, and functional assays to confirm that the recombinant protein retains native properties and activity .
For membrane proteins like plsY, additional considerations include the use of appropriate detergents during extraction and purification to maintain protein solubility and function.
E. coli expression systems have been successfully used for various F. tularensis proteins. Key considerations include:
Promoter selection: The F. tularensis groES promoter has been effectively used to drive gene expression in heterologous systems .
Codon optimization: Adjusting codon usage to match the expression host can improve yields.
Signal peptide evaluation: For exported proteins, maintaining the native signal peptide may be important. For instance, catalase-peroxidase (KatG) from F. tularensis exhibits a functional signal peptide that facilitates export even in recombinant E. coli host cells .
Post-translational consideration: Some F. tularensis proteins undergo post-translational modifications, such as the multiple modifications observed on the universal stress protein (Usp), including lysine acetylation and glutamine polyamination .
Post-translational modifications (PTMs) can significantly impact protein function. For characterizing PTMs in F. tularensis proteins:
Mass spectrometry analysis: This technique has revealed PTMs on F. tularensis proteins. For example, recombinant F. tularensis universal stress protein (rUsp/His6) exhibited an apparent molecular weight of 33 kDa despite a predicted 30 kDa, with mass spectrometry confirming multiple PTMs including lysine acetylation and glutamine polyamination .
Comparative analysis: Comparing molecular weights of recombinant versus native proteins can indicate potential PTMs. Discrepancies between predicted and observed weights should be investigated further.
Site-directed mutagenesis: Mutating specific residues suspected of undergoing PTMs can help determine their functional significance.
Specific enzymatic treatments: Using deacetylases or other modification-removing enzymes can confirm the presence and functional role of specific PTMs.
Transposon mutagenesis is a powerful tool for studying gene function in F. tularensis:
Temperature-sensitive Tn5 delivery system: A specialized system has been developed for F. tularensis that enables generation of chromosomal reporter fusions with lacZ or luxCDABE. This system uses:
Recovery rates: Approximately 0.1% of bacterial populations carrying the transposon delivery plasmid develop chromosomal insertions when subjected to high-temperature selection .
Insertion characteristics: Nucleotide sequence analysis confirms that insertions occur randomly throughout the chromosome, making this system suitable for creating saturating mutant libraries .
Reporter systems: The system can create chromosomal luxCDABE or lacZ transcriptional reporter fusions, enabling monitoring of gene expression under various conditions .
For investigating membrane protein topology and localization:
Bioinformatic prediction combined with experimental validation: Six independent bioinformatic analyses have been used to identify membrane proteins in F. tularensis, followed by experimental verification using recombinant proteins and polyclonal antisera as strategic probes .
Sucrose density gradient ultracentrifugation: This "gold standard" method has been adapted for separating F. tularensis outer membranes (OMs) and inner membranes (IMs). Notably, F. tularensis OMs typically migrate in sucrose gradients between densities of 1.17 and 1.20 g/ml, which differs from densities observed for other gram-negative bacteria (1.21 to 1.24 g/ml) .
Two-dimensional electrophoresis with mass spectrometric analysis: This approach has been effective for identifying immunogenic proteins in F. tularensis membrane fractions .
Recombinant expression with epitope tags: This allows detection and localization studies using tag-specific antibodies when native antibodies are unavailable.
Immunofluorescence microscopy: This can confirm subcellular localization patterns when combined with specific antibodies.
For enzymatic characterization of recombinant plsY:
Substrate specificity assessment: Similar to studies with F. tularensis acid phosphatase, recombinant plsY should be tested with various substrates to determine its specificity profile .
pH optimum determination: Enzymatic assays should be conducted across a pH range to establish optimal conditions, as has been done for other F. tularensis enzymes .
Inhibitor sensitivity profiling: Testing sensitivity and resistance to various inhibitors helps characterize the enzyme's active site and can identify potential therapeutic targets .
Kinetic parameter determination: Measuring Km, Vmax, and catalytic efficiency under standardized conditions provides fundamental insights into enzyme function.
Activity comparison: Comparing the enzymatic properties of recombinant plsY with those of the native enzyme (if available) can verify that the recombinant form maintains physiologically relevant characteristics .
Growth medium composition significantly impacts F. tularensis protein expression:
Comparative expression analysis: Studies have shown differential gene expression when F. tularensis is grown on modified Mueller-Hinton (MMH) versus Chamberlain's defined medium (CDM) .
Virulence factor induction: Growth on CDM has been reported to result in:
Monitoring approaches: Transcriptional reporter libraries using luxCDABE or lacZ fusions have successfully identified both established virulence genes and novel genes that may play roles in pathogenesis when comparing growth on different media .
Stress response correlation: The expression of certain proteins, such as Usp, remains consistently high under various stress conditions, including nutrient deprivation, low pH, and oxidative stress .
The relationship between stress response and membrane proteins in F. tularensis reveals important aspects of bacterial adaptation:
Oxidative stress resistance: F. tularensis proteins like Usp play protective roles against oxidative stress. The deletion of usp results in impaired growth and recovery under paraquat-induced oxidative stress .
Transcriptional regulation: Stress response proteins can support the expression of key antioxidant defense genes. For example, Usp supports the expression of oxyR and katG in F. tularensis .
Environmental adaptation: Membrane proteins often function in sensing and responding to environmental changes. F. tularensis can survive under diverse environmental and host-induced stress conditions, with membrane components playing critical roles in this adaptation .
Protein half-life considerations: Some stress-response proteins display remarkable stability. For instance, F. tularensis usp mRNA has a half-life exceeding 30 minutes, with protein and transcript levels remaining consistently high under various stress conditions .
Membrane proteins present unique challenges for recombinant expression:
Expression system optimization:
Using specialized E. coli strains designed for membrane protein expression
Testing different growth temperatures (often lower temperatures improve folding)
Employing fusion partners that enhance solubility
Extraction strategies:
Selection of appropriate detergents for solubilization
Screening different detergent:protein ratios
Implementing step-wise extraction protocols
Purification approaches:
Using detergent exchange during purification
Incorporating stabilizing agents in purification buffers
Considering native lipid addition to maintain function
Alternative expression formats:
Cell-free expression systems with lipid nanodiscs
Amphipol stabilization for structural studies
Expression as truncated soluble domains where appropriate
For studying protein-protein interactions:
Co-immunoprecipitation: Using antibodies against the target protein to pull down interaction partners.
Bacterial two-hybrid systems: Adapted for membrane protein interactions.
Cross-linking studies: Chemical cross-linking followed by mass spectrometry to identify interacting partners.
Pull-down assays: Using recombinant tagged proteins as bait to identify interaction partners from bacterial lysates.
Biolayer interferometry or surface plasmon resonance: For measuring binding kinetics between purified components.
Blue native PAGE: For preserving and analyzing multi-protein complexes.
Structural characterization approaches that inform drug development include:
X-ray crystallography: Determining high-resolution structures of purified recombinant protein.
Cryo-electron microscopy: Especially useful for membrane proteins that are difficult to crystallize.
Structure-based drug design: Using structural data to identify potential binding pockets and design inhibitors.
Molecular docking studies: In silico screening of compound libraries against structural models.
Site-directed mutagenesis: Validating key residues identified in structural studies to confirm their importance for function and potential drug binding.
Fragment-based drug discovery: Testing small molecular fragments for binding to specific protein regions.
For robust enzyme kinetics analysis:
Non-linear regression analysis: Rather than linear transformations (Lineweaver-Burk plots), non-linear regression directly fitting to the Michaelis-Menten equation provides more accurate parameter estimates.
Global fitting approaches: When analyzing inhibitor studies, global fitting of multiple datasets simultaneously improves parameter estimation.
Bootstrap resampling: This technique provides more realistic error estimates for kinetic parameters.
Model discrimination: Statistical tests to determine whether more complex kinetic models (substrate inhibition, allosteric effects) are justified by the data.
Replicate design considerations:
Minimum of three independent protein preparations
Technical replicates within each preparation
Controlling for batch effects in statistical analysis
Standardization and validation practices include:
Assay development controls:
Positive controls using well-characterized enzymes
Negative controls with heat-inactivated enzyme
Substrate-only and enzyme-only controls
Validation parameters:
Linearity assessment across concentration ranges
Precision determination (intra-day and inter-day)
Limit of detection and quantification establishment
Specificity confirmation through inhibitor studies
Reference standards:
Comparison to native enzyme when available
Use of commercial enzyme standards when applicable
Internal laboratory reference preparations
Assay robustness testing:
pH and buffer composition influence
Temperature sensitivity
Storage stability assessment
Freeze-thaw cycle impacts
| Validation Parameter | Acceptance Criteria | Typical Methodology |
|---|---|---|
| Linearity | R² > 0.98 | Multiple substrate concentrations |
| Precision | CV < 10% | Replicate analyses |
| Specificity | Activity reduction > 90% with specific inhibitors | Inhibitor studies |
| Stability | Activity retention > 85% | Time-course studies |
| pH Optimum | Activity > 50% of maximum | pH range testing |
F. tularensis is classified as a category A select agent by the CDC, necessitating stringent safety protocols:
Biosafety level requirements:
Work with live F. tularensis requires BSL-3 facilities
Recombinant proteins may be handled at BSL-2 with appropriate risk assessment
Institutional biosafety committee approval is mandatory
Containment strategies:
Use of biological safety cabinets
Appropriate personal protective equipment
Validated decontamination procedures
Regulatory compliance:
Select agent registration requirements
Documentation and inventory control
Restricted personnel access
Alternative approaches:
Using attenuated strains like LVS for initial studies
Employing non-pathogenic heterologous expression systems
Developing cell-free experimental systems where applicable
Common expression challenges and solutions include:
Low expression levels:
Protein misfolding:
Co-expression with molecular chaperones
Incorporation of fusion partners
Expression at reduced temperatures (16-25°C)
Addition of specific lipids during expression
Proteolytic degradation:
Using protease-deficient expression strains
Addition of protease inhibitors during purification
Optimizing extraction and purification speed
Toxic effects on host cells:
Using tightly regulated inducible systems
Employing specialized expression strains
Testing cell-free expression systems
To achieve adequate protein yields:
Scale-up approaches:
Bioreactor cultivation with optimized parameters
High-density fermentation protocols
Fed-batch cultivation strategies
Purification optimization:
Multi-step chromatography protocols
High-capacity affinity resins
Automated purification systems
Stabilization strategies:
Buffer optimization screening
Addition of specific ligands or co-factors
Appropriate storage conditions validation
Expression enhancement:
Emerging structural biology approaches offer new opportunities:
Integrative structural biology:
Combining X-ray crystallography, cryo-EM, and NMR data
Small-angle X-ray scattering for studying conformational dynamics
Mass photometry for analyzing protein complexes
In situ structural studies:
Cryo-electron tomography of F. tularensis cells
Correlative light and electron microscopy
In-cell NMR spectroscopy
Time-resolved structural methods:
Time-resolved crystallography for capturing enzymatic intermediates
Temperature-jump studies coupled with structural analysis
Hydrogen-deuterium exchange mass spectrometry for conformational dynamics
Computational approaches:
Molecular dynamics simulations of membrane-embedded plsY
Quantum mechanics/molecular mechanics studies of catalytic mechanisms
Deep learning-based structure prediction and validation
Cutting-edge approaches for host-pathogen studies include:
Advanced imaging techniques:
Super-resolution microscopy for localizing proteins during infection
Live-cell imaging with genetically encoded sensors
Correlative light and electron microscopy of infected cells
High-throughput functional genomics:
CRISPR interference/activation screening in host cells
Dual RNA-seq of host-pathogen interactions
Proteomics of purified pathogen-containing vacuoles
Organoid and tissue models:
3D lung organoids for studying host-pathogen interactions
Organ-on-chip technologies for physiologically relevant models
Ex vivo tissue infection models
Single-cell analysis:
Single-cell RNA-seq of infected host populations
Mass cytometry for high-dimensional analysis
Spatial transcriptomics of infected tissues
Comprehensive evaluation of potential inhibitors includes:
Initial screening approaches:
Structure-based virtual screening
Fragment-based screening
High-throughput enzymatic assays
Phenotypic screening with bacterial growth inhibition
Mechanism validation:
Enzyme kinetics to determine inhibition mechanisms
Binding affinity measurements (ITC, SPR, MST)
Structural studies of enzyme-inhibitor complexes
Activity against mutant enzymes to confirm specificity
Cellular efficacy assessment:
Intracellular activity against F. tularensis in macrophages
Cytotoxicity evaluation in mammalian cells
Effect on bacterial membrane composition and integrity
Resistance development monitoring
In vivo evaluation pipeline:
Pharmacokinetic and pharmacodynamic profiling
Efficacy in animal models of tularemia
Combination studies with existing antibiotics
Safety and toxicity assessment